Next Article in Journal
Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine
Next Article in Special Issue
Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
Previous Article in Journal
Adverse Reactions after BNT162b2 Messenger RNA Vaccination for Coronavirus Disease 2019 in Healthcare Workers Compared with Influenza Vaccination
Previous Article in Special Issue
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 366; https://doi.org/10.3390/vaccines11020366
Action Date Notes Link
article xml file uploaded 6 February 2023 06:26 CET Original file -
article xml uploaded. 6 February 2023 06:26 CET Update https://www.mdpi.com/2076-393X/11/2/366/xml
article pdf uploaded. 6 February 2023 06:26 CET Version of Record https://www.mdpi.com/2076-393X/11/2/366/pdf
article html file updated 6 February 2023 06:27 CET Original file https://www.mdpi.com/2076-393X/11/2/366/html
Back to TopTop